Patents by Inventor David W. Schultz
David W. Schultz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11497712Abstract: The present disclosure provides a method of preparing a pharmaceutical composition. The method includes transferring a predetermined quantity of an excipient mixture from a second vessel to a first vessel. The excipient mixture transferred from the second vessel includes a liquid-state second quantity of a hydrofluoroalkane propellant and a first solubilized excipient comprising a low-molecular weight poly(ethylene oxide) polymer. The method further includes contacting at least one pharmaceutically-active compound with the excipient mixture under conditions that facilitate forming an intermixture comprising the propellant, the polymer, and the compound. Before transferring the excipient mixture, the first vessel contains a vapor-phase first quantity of the hydrofluoroalkane propellant and an effective amount of the at least one pharmaceutically-active compound.Type: GrantFiled: February 22, 2019Date of Patent: November 15, 2022Assignee: Kindeva Drug Delivery L.P.Inventors: Stephen W. Stein, David W. Schultz, John K. Simons, William F. Hansen
-
Publication number: 20190183784Abstract: The present disclosure provides a method of preparing a pharmaceutical composition. The method includes transferring a predetermined quantity of an excipient mixture from a second vessel to a first vessel. The excipient mixture transferred from the second vessel includes a liquid-state second quantity of a hydrofluoroalkane propellant and a first solubilized excipient comprising a low-molecular weight poly(ethylene oxide) polymer. The method further includes contacting at least one pharmaceutically-active compound with the excipient mixture under conditions that facilitate forming an intermixture comprising the propellant, the polymer, and the compound. Before transferring the excipient mixture, the first vessel contains a vapor-phase first quantity of the hydrofluoroalkane propellant and an effective amount of the at least one pharmaceutically-active compound.Type: ApplicationFiled: February 22, 2019Publication date: June 20, 2019Applicant: 3M INNOVATIVE PROPERTIES COMPANYInventors: STEPHEN W. STEIN, DAVID W. SCHULTZ, JOHN K. SIMONS, WILLIAM F. HANSEN
-
Patent number: 10140781Abstract: A vehicle wireless information system includes a vehicle, an onboard vehicle computer provided in the vehicle and at least one external access point adapted to wirelessly access the onboard vehicle computer.Type: GrantFiled: April 15, 2009Date of Patent: November 27, 2018Assignee: Ford Global Technologies, LLCInventors: Bruce Carvell Blakemore, Allan Roy Gale, Bala Chander, David W Schultz, Paul Theodore Momcilovich, Dale Gilman
-
Publication number: 20180071231Abstract: Compositions containing albuterol, ipratropium, and a propellant as well as aerosol canisters and inhalers, such as metered dose inhalers, containing such compositions.Type: ApplicationFiled: April 7, 2016Publication date: March 15, 2018Inventors: KEWU ZHU, DAVID W. SCHULTZ, JAMES B. DRAKE, YU CHEN, MEI-LING PAN, ENG SENG YAP
-
Publication number: 20170189329Abstract: The present disclosure provides a method of preparing a pharmaceutical composition. The method includes transferring a predetermined quantity of an excipient mixture from a second vessel to a first vessel. The excipient mixture transferred from the second vessel includes a liquid-state second quantity of a hydrofluoroalkane propellant and a first solubilized excipient comprising a low-molecular weight poly(ethylene oxide) polymer. The method further includes contacting at least one pharmaceutically-active compound with the excipient mixture under conditions that facilitate forming an intermixture comprising the propellant, the polymer, and the compound. Before transferring the excipient mixture, the first vessel contains a vapor-phase first quantity of the hydrofluoroalkane propellant and an effective amount of the at least one pharmaceutically-active compound.Type: ApplicationFiled: July 28, 2015Publication date: July 6, 2017Applicant: 3M INNOVATIVE PROPERTIES COMPANYInventors: STEPHEN W. STEIN, DAVID W. SCHULTZ, JOHN K. SIMONS, WILLIAM F. HANSEN
-
Patent number: 8125180Abstract: An electrical port is integrated within a side view mirror assembly of an automotive vehicle. The electrical port is electrically connected with a charging system of the vehicle. The electrical port may be coupled with a power source remote from the vehicle to power the charging system. The electrical port may be concealed or exposed depending on a position of the side view mirror assembly.Type: GrantFiled: May 12, 2008Date of Patent: February 28, 2012Assignee: Ford Global Technologies, LLCInventors: Duane M. Grider, Bala Chander, Dale Gilman, David W. Schultz, Michael Kevin Martin
-
Patent number: 8058841Abstract: The present invention is generally directed to a retractable overhead charging cord dispenser which has multi-positioning capability to provide plug-in electric power to PHEVs parked at various positions in a garage or the like. An illustrative embodiment of the retractable overhead charging cord dispenser includes an arm assembly, a cord guide arm carried by the arm assembly, a cord storage device provided in the arm assembly and a retractable charging cord extendable from the cord storage device and extending through and protruding from the cord guide arm.Type: GrantFiled: October 25, 2008Date of Patent: November 15, 2011Assignee: Ford Global Technologies, LLCInventors: Bala Chander, Ted James Miller, David W Schultz, Dale Gilman
-
Publication number: 20100268401Abstract: A vehicle wireless information system includes a vehicle, an onboard vehicle computer provided in the vehicle and at least one external access point adapted to wirelessly access the onboard vehicle computer.Type: ApplicationFiled: April 15, 2009Publication date: October 21, 2010Inventors: Bruce Carvell Blakemore, Allan Roy Gale, Bala Chander, David W. Schultz, Paul Theodore Momcilovich, Dale Gilman
-
Publication number: 20100102775Abstract: The present invention is generally directed to a retractable overhead charging cord dispenser which has multi-positioning capability to provide plug-in electric power to PHEVs parked at various positions in a garage or the like. An illustrative embodiment of the retractable overhead charging cord dispenser includes an arm assembly, a cord guide arm carried by the arm assembly, a cord storage device provided in the arm assembly and a retractable charging cord extendable from the cord storage device and extending through and protruding from the cord guide arm.Type: ApplicationFiled: October 25, 2008Publication date: April 29, 2010Inventors: Bala Chander, Ted James Miller, David W. Schultz, Dale Gilman
-
Patent number: 7687054Abstract: Methods, compounds, and medicinal formulations utilizing biocompatible polymers for delivery of a drug, particularly for solubilizing, stabilizing and/or providing sustained release of drug from topical, implantable, and inhalation systems. Many of the methods, compounds, and medicinal formulations are particularly suitable for oral and/or nasal inhalation and use polymers of the formula —[X—R1—C(O)]— wherein each R1 is an independently selected organic group that links the —X— group to the carbonyl group, and each X is independently oxygen, sulfur, or catenary nitrogen.Type: GrantFiled: February 18, 2002Date of Patent: March 30, 2010Assignee: 3M Innovative Properties CompanyInventors: James S. Stefely, David W. Schultz, Chester L. Leach, Daniel C. Duan
-
Publication number: 20090278491Abstract: An electrical port is integrated within a side view mirror assembly of an automotive vehicle. The electrical port is electrically connected with a charging system of the vehicle. The electrical port may be coupled with a power source remote from the vehicle to power the charging system. The electrical port may be concealed or exposed depending on a position of the side view mirror assembly.Type: ApplicationFiled: May 12, 2008Publication date: November 12, 2009Applicant: FORD GLOBAL TECHNOLOGIES, LLCInventors: Duane M. Grider, Bala Chander, Dale Gilman, David W. Schultz, Michael Kevin Martin
-
Patent number: 7105152Abstract: Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.Type: GrantFiled: May 31, 1995Date of Patent: September 12, 2006Assignee: 3M Innovative Properties CompanyInventors: Robert K. Schultz, David W. Schultz, Robert A. Moris
-
Patent number: 7101534Abstract: Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.Type: GrantFiled: May 31, 1995Date of Patent: September 5, 2006Assignee: 3M Innovative Properties CompanyInventors: Robert K. Schultz, David W. Schultz, Robert A. Moris
-
Publication number: 20040197273Abstract: A pharmaceutical suspension aerosol formulation containing HFA-227 as a propellant.Type: ApplicationFiled: April 9, 2004Publication date: October 7, 2004Applicant: 3M COMPANYInventors: Robert K. Schultz, David W. Schultz, Martin J. Oliver, Robert A. Moris, Philip A. Jinks
-
Patent number: 6743413Abstract: Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.Type: GrantFiled: May 31, 1995Date of Patent: June 1, 2004Assignee: 3M CompanyInventors: Robert K. Schultz, David W. Schultz, Martin J. Oliver, Robert A. Moris, Philip A. Jinks
-
Publication number: 20040013611Abstract: Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.Type: ApplicationFiled: July 9, 2003Publication date: January 22, 2004Applicant: Minnesota Mining and Manufacturing Company, now 3M CompanyInventors: Robert K. Schultz, David W. Schultz, Martin J. Oliver, Robert A. Moris, Philip A. Jinks
-
Publication number: 20030103907Abstract: Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.Type: ApplicationFiled: August 8, 2002Publication date: June 5, 2003Inventors: Robert K. Schultz, David W. Schultz, Martin J. Oliver, Robert A. Moris, Philip A. Jinks
-
Publication number: 20020164290Abstract: Methods, compounds, and medicinal formulations utilizing biocompatible polymers for delivery of a drug, particularly for solubilizing, stabilizing and/or providing sustained release of drug from topical, implantable, and inhalation systems. Many of the methods, compounds, and medicinal formulations are particularly suitable for oral and/or nasal inhalation and use polymers of the formula —[X—R1—C(O)]— wherein each R1 is an independently selected organic group that links the —X— group to the carbonyl group, and each X is independently oxygen, sulfur, or catenary nitrogen.Type: ApplicationFiled: February 18, 2002Publication date: November 7, 2002Applicant: 3M Innovative Properties CompanyInventors: James S. Stefely, David W. Schultz, Chester L. Leach, Daniel C. Duan
-
Patent number: 6416742Abstract: Methods, compounds, and medicinal formulations utilizing biocompatible polymers for delivery of a drug, particularly for solubilizing, stabilizing and/or providing sustained release of drug from topical, implantable, and inhalation systems. Many of the methods, compounds, and medicinal formulations are particularly suitable for oral and/or nasal inhalation and use polymers of the formula —[X—R1—C(O)]— wherein each R1 is an independently selected organic group that links the —X— group to the carbonyl group, and each X is independently oxygen, sulfur, or catenary nitrogen.Type: GrantFiled: August 9, 2000Date of Patent: July 9, 2002Assignee: 3M Innovative Properties CompanyInventors: James S. Stefely, David W. Schultz, Luke E. Schallinger, Craig A. Perman, Chester L. Leach, Daniel C. Duan
-
Patent number: 6346232Abstract: Pharmaceutical solution aerosol formulations comprising beclomethasone 17,21 dipropionate, ethanol, and a propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane, and a mixture thereof.Type: GrantFiled: March 29, 2000Date of Patent: February 12, 2002Assignee: 3M Innovative Properties CompanyInventors: Robert K. Schultz, David W. Schultz